Harm Reduction Therapeutics (HRT), Inc.
Harm Reduction Therapeutics (HRT), Inc., headquartered in the United States, is a pioneering organisation in the field of harm reduction and public health. Founded in 2018, HRT focuses on developing innovative solutions to address the opioid crisis and other substance use challenges. The company operates primarily across the US, with a commitment to improving health outcomes through evidence-based practices. HRT's core offerings include the development of low-cost, accessible naloxone products, which are essential in reversing opioid overdoses. What sets HRT apart is its dedication to affordability and community accessibility, ensuring that life-saving interventions reach those in need. With a strong market position, HRT has garnered recognition for its impactful contributions to harm reduction, making significant strides in public health advocacy and education.
DitchCarbon Score
How does Harm Reduction Therapeutics (HRT), Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Harm Reduction Therapeutics (HRT), Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Harm Reduction Therapeutics (HRT), Inc.'s reported carbon emissions
Harm Reduction Therapeutics (HRT), Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. As HRT does not inherit emissions data from a parent company or corporate family, it operates independently in terms of climate commitments. Without specific emissions data or reduction initiatives, it is unclear how HRT plans to address its carbon footprint or contribute to broader climate goals within the industry. In the context of climate action, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, HRT's current lack of emissions reporting and reduction strategies highlights a potential area for future development in their sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Harm Reduction Therapeutics (HRT), Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
